{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:38:49Z","timestamp":1760297929854},"reference-count":21,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T00:00:00Z","timestamp":1205280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Secretory type\u2010II phospholipase A<jats:sub>2<\/jats:sub> (sPLA<jats:sub>2<\/jats:sub>\u2010II) is a cardiovascular risk marker since higher levels of this acute phase protein imply an increased risk for coronary artery disease. Moreover, it is hypothesized that local activity of sPLA<jats:sub>2<\/jats:sub>\u2010II in the atherosclerotic plaque facilitates an inflammatory response to induce plaque instability or rupture. We have studied the presence of sPLA<jats:sub>2<\/jats:sub>\u2010II in culprit lesions in the coronary arteries of patients with acute myocardial infarction (AMI) or angina pectoris.<\/jats:p><jats:p><jats:bold>Materials and methods\u2002<\/jats:bold> We performed a histological examination of culprit lesions in 41 patients with stable (SAP) or unstable angina pectoris (UAP), or AMI using directed coronary atherectomy (DCA). Frozen slides were analysed immuno\u2010histochemically for the presence of sPLA<jats:sub>2<\/jats:sub>\u2010II, macrophages and smooth muscle cells. Immunopositive areas were calculated as a percentage of the total tissue area using image analysis software.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Intracellular sPLA<jats:sub>2<\/jats:sub>\u2010II was found in atherosclerotic lesions in the macrophages of the intima as well as in vascular smooth muscle cells. Next to this, extracellular sPLA<jats:sub>2<\/jats:sub>\u2010II depositions were also found. These depositions were significantly more extensive in patients with AMI, i.e. 26%<jats:sup>median<\/jats:sup>[6%<jats:sup>25th(percentile)<\/jats:sup>\u201344%<jats:sup>75th(percentile)<\/jats:sup>] of the intima area, than in patients with SAP 0%<jats:sup>median<\/jats:sup> (0%<jats:sup>25th<\/jats:sup>\u201310%<jats:sup>75th<\/jats:sup>; <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7013) or UAP 0%<jats:sup>median<\/jats:sup> (0%<jats:sup>25th<\/jats:sup>\u20130%<jats:sup>75th<\/jats:sup>;<jats:italic> P<\/jats:italic>\u00a0=\u00a00\u00b704).<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Extracellular sPLA<jats:sub>2<\/jats:sub>\u2010II is more abundantly present in atherosclerotic culprit lesions that have led to myocardial infarction. This suggests a role for extracellular sPLA<jats:sub>2<\/jats:sub>\u2010II in the development of complications of atherosclerotic lesions in coronary arteries.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2008.01933.x","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T04:36:50Z","timestamp":1205383010000},"page":"205-210","source":"Crossref","is-referenced-by-count":12,"title":["Secretory type II phospholipase A<sub>2<\/sub> in culprit coronary lesions is associated with myocardial infarction"],"prefix":"10.1111","volume":"38","author":[{"given":"R.","family":"Nijmeijer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Meuwissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. A. J.","family":"Krijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Van Der Wal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Piek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. E.","family":"Hack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. W. M.","family":"Niessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,12]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(93)90071-Q"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)01069-9"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s003950070041"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2002.00966.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2002.01000.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.54.3.947585"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.80.2.410"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(89)90117-8"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(99)00045-3"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.10.2257"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.2.300"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.18.4.519"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.20.5.1276"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M002783200"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(01)00480-1"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(98)00318-6"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1009647912056"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00887.2002"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2005.027235"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.2174\/187152906777441830"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.15.1845"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2008.01933.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2008.01933.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T19:41:15Z","timestamp":1695757275000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2008.01933.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,12]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1111\/j.1365-2362.2008.01933.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2008.01933.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,12]]}}}